Volpara Health is transforming breast cancer detection through its mind-boggling AI software, helping healthcare providers improve early diagnosis and patient outcomes.
Breast cancer remains one of the most pressing health concerns worldwide, but technological advancements are resulting in early detection and helping save more families from cancer.
Volpara Health, a company founded in Wellington, New Zealand, has developed AI-driven software that enhances the accuracy and efficiency of breast cancer screening.
With a presence in over 2,000 healthcare facilities globally, its technology impacts nearly 15 million patients each year.
In 2022, over 2.3 million women throughout the world were diagnosed with breast cancer, with over 670,000 deaths attributed to breast cancer that year.
Tana Isaac, Volpara Health's Executive Vice President of Product and Technology, spoke with TechDay during an exclusive interview, to discuss the crucial role AI is playing in saving lives.
Read the full article here
